KBI Biopharma Strengthens Leadership


CDMO makes four new executive appointments.

Business shaking hands, finishing up meeting. Successful businessmen handshaking after good deal. Image Credit: Adobe Stock Images/Katsiaryna

Image Credit: Adobe Stock Images/Katsiaryna

KBI Biopharma, Inc. (KBI), a JSR Life Sciences company and contract development and manufacturing organization (CDMO), has made four recent executive appointments. Joining the company are Tony Fraij, COO; Shaguna Seth, chief of staff and global PMO leader; Katie Edgar, SVP of corporate strategy and alliance management; and Sarah Wakefield, SVP, corporate communications.

“I am thrilled to welcome these four exceptional experts to KBI. Each of them brings unique insight, has an impressive track record, and is fully aligned with our KBI vision as we navigate the evolving landscape of our industry and seize opportunities for success,” said J.D. Mowery, KBI Biopharma CEO. “They will all play vital roles in shaping our future at KBI, enabling us to be the best and most trusted partner to our global biopharmaceutical customers.”

Related Videos
© 2024 MJH Life Sciences

All rights reserved.